Veterinary Medicines

Parofor 175 mg/ml Solution for injection

Authorised
  • Paromomycin sulfate
Download as PDF

Product identification

Medicine name:
Parofor 175 mg/ml Solution for injection
Parofor 175 mg/ml oldatos injekció sertések számára A.U.V.
Active substance:
  • Paromomycin sulfate
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Paromomycin sulfate
    250.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        20
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:
  • Parofor 175 mg/ml inj. sol. i.m. vial 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet J.S.C.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
  • 4009/X/18 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • Belgium
Procedure number:
  • BE/V/0027/003
Concerned member states:
  • Czechia
  • Denmark
  • Estonia
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)
Generic of:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."